Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.

New Owner

Astellas Pharma - Ocata Therapeutics

Astellas Pharma acquires Ocata Therapeutics

Announced: November 10, 2015

Type:           Acquisition
Disposition: Combined
Terms:         Cash
Status:         Complete

Amount:       $ 380,000,000

Acquisition News

Add News

Date Title
There are no news.

Astellas Pharma Other Acquisitions

Add Acquisition

Date Acquired Amount
Apr 02, 2017
Ogeda
€ 500,000,000
Oct 28, 2016
Ganymed Pharmaceuticals
$ 1,400,000,000
May 16, 2010
OSI Pharmaceuticals
$ 4,000,000,000
Dec 27, 2007
Agensys
$ 387,000,000